Nurs 684 Actual Exam Test #2 Latest Version With Updated Questions And Accurate Answersverified Answers Graded A+

3/15/25, 8:54 AM NUR 684- Test #2



NUR 684- Test #2



NURS 684 ACTUAL EXAM TEST #2 LATEST VERSION
WITH UPDATED QUESTIONS AND ACCURATE
ANSWERS\\VERIFIED ANSWERS GRADED A+




NuvaRing- % of women 0.3% will be pregnant with perfect use
experiencing an unintended
pregnancy within first year of
use (perfect use)
Depo-Provera- % of women 6% will be pregnant with typical use
experiencing an unintended
pregnancy within first year of
use (typical use)
Depo- Provera- % of women 0.2% will be pregnant with perfect use
experiencing an unintended
pregnancy within first year of
use (perfect use)
Paragard copper IUD- % of 0.8% will be pregnant with typical use
women experiencing an
unintended pregnancy within
first year of use (typical use)
Paragard copper IUD- % of 0.6% will be pregnant with perfect use
women experiencing an
unintended pregnancy within
first year of use (perfect use)
Mirena IUD- % of women 0.2% will be pregnant with typical use
experiencing an unintended
pregnancy within first year of
use (typical use)
Mirena IUD- % of women 0.2% will be pregnant with perfect use
experiencing an unintended

/ 1/20

,3/15/25, 8:54 AM NUR 684- Test #2

pregnancy within first year of
use (perfect use)

Implanon- % of women 0.05% will be pregnant with typical use
experiencing an unintended
pregnancy within first year of
use (typical use)
Implanon- % of women 0.05% will be pregnant with perfect use
experiencing an unintended
pregnancy within first year of
use (perfect use)
Female sterilization- % of 0.5% will be pregnant with typical use
women experiencing an
unintended pregnancy within
first year of use (typical use)
Female sterilization- % of 0.5% will be pregnant with perfect use
women experiencing an
unintended pregnancy within
first year of use (perfect use)
Male sterilization- % of 0.15% will be pregnant with typical use
women experiencing an
unintended pregnancy within
first year of use (typical use)
Male sterilization- % of 0.10% will be pregnant with perfect use
women experiencing an
unintended pregnancy within
first year of use (perfect use)


-Rifampicin & rifabutin
-Griseofulvin
Drugs that may decrease
-St. John's wort
contraceptive efficacy -Some anticonvulsants
-Some antiretrovirals
Categories of MEC for No restriction for the use of the contraceptive method for
Contraceptive Use- 1 a woman with that condition
Categories of MEC for Advantages of using the method generally outweigh the theoretical or
Contraceptive Use- 2 proven risks

Theoretical or proven risks of the method usually
Categories of MEC for
outweigh the advantages - not usually recommended
Contraceptive Use- 3
unless more appropriate methods are not available or

/ 2/20

, 3/15/25, 8:54 AM NUR 684- Test #2

acceptable



Categories of MEC for Unacceptable health risk if the contraceptive method is
Contraceptive Use- 4 used by a woman with that condition
-Combined oral contraceptives
Combination Hormonal
-NuvaRing
Contraception (examples)
-Patch
-Less than 21 days postpartum
-Age 35 or older & smoking 15 or more cigarettes a day


-Hypertension of 160/100 or higher
-DVT or PE
-Major surgery with prolonged immobilization
-Thrombogenic mutations
Category 4 conditions for -Ischemic heart disease or stroke
combined hormonal -Valvular heart disease
contraception
-Current breast cancer
-Active viral hepatitis / cirrhosis
-Lupus
-Diabetes with neuropathy
-Migraine with aura
-21-42 days postpartum in non-
breastfeeding women with other risk
factors for VTE
-21-<30 days postpartum in all breastfeeding women
-30-42 days postpartum in breastfeeding women with other risk factors
for VTE
Category 3 conditions for -Age 35 or older & smoking <15 cigarettes/day
combined hormonal
contraception -History of breast cancer (no evidence of disease 5+ yrs)
-History of DVT or PE
-Controlled HTN


-Hyperlipidemias
-Inflammatory bowel disease
-Rifampicin or rifabutin therapy
-DMPA
Progestin-only Contraception -Progestin only pills
(examples) -Nexplanon
Category 4 conditions for *Breast cancer within past 5 years*
progestin-only contraception


/ 3/20